In Vitro Evaluations of Aminopenicillin/β-Lactamase Inhibitor Combinations

This publication has 14 references indexed in Scilit:

• Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes
  Antimicrobial Agents and Chemotherapy, 1986
• In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with β-lactamase inhibitors
  Journal of Antimicrobial Chemotherapy, 1986
• Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin
  Antimicrobial Agents and Chemotherapy, 1984
• Plasmid-determined β-lactamases identified in a group of 204 ampicillin-resistant Enterobacteriaceae
  Journal of Antimicrobial Chemotherapy, 1983
• Effects of ampicillin plus sulbactam on bowel flora in patients undergoing colorectal surgery
  Antimicrobial Agents and Chemotherapy, 1982
• Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration
  Antimicrobial Agents and Chemotherapy, 1982
• A three-way crossover study to compare the pharmacokinetics and acceptability of Sultamicillin at two dose levels with that of ampicillin
  Journal of Antimicrobial Chemotherapy, 1982
• Principal beta-lactamases responsible for resistance to beta-lactam antibiotics in urinary tract infections
  Antimicrobial Agents and Chemotherapy, 1980
• CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and Bacteroides
  Antimicrobial Agents and Chemotherapy, 1980
• A sulfone .BETA.-lactam compound which acts as a .BETA.-lactamase inhibitor.
  The Journal of Antibiotics, 1978